Google is again facing questions from regulators about its $2.1 billion bid for Fitbit. The biggest sticking point: How will the tech giant use Fitbit’s trove of health data?
Google is staring down the possibility of a sweeping antitrust investigation launched by regulators in the European Union, which would become the latest in a series of probes into the deal. But the tech giant could sidestep that investigation by making a binding pledge not to use Fitbit’s health data for advertising purposes, Reuters reported this week. The deadline for Google to make such a concession is July 13. The European Commission, which is overseeing the probe, is scheduled to make a decision by July 20.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
